Currently submitted to: Transfer Hub (manuscript eXchange)
Date Submitted: Apr 5, 2026
Open Peer Review Period: Apr 8, 2026 - Jun 3, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Risk Factors of Arteriovenous Fistula Stenosis in Hemodialysis Patients Using Electronic Stethoscope Monitoring: A Prospective Cohort Study
ABSTRACT
Background:
Taiwan has the world’s highest prevalence of hemodialysis (HD), with arteriovenous fistula (AVF) stenosis representing a critical complication affecting dialysis adequacy and patient outcomes. Traditional AVF monitoring relies on clinical expertise and subjective assessment, potentially delaying stenosis detection.
Objective:
This study aimed to evaluate electronic stethoscope monitoring for early AVF stenosis detection compared to traditional nursing assessment, and identify risk factors associated with AVF stenosis in HD patients.
Methods:
We conducted a 3-month prospective study at National Taiwan University Hospital Yunlin Branch Hemodialysis Center from March to June 2023. Thirty adult HD patients with AVF (>3 months dialysis vintage) were enrolled. AVF sounds were recorded 2-6 times weekly at two locations: 3cm proximal to the anastomosis and the arterial needle insertion site. Sound signals were converted to decibel (dB) measurements using short-time Fourier transform. Clinical and demographic data were collected including monthly albumin levels, blood pressure (BP), dialysis parameters, and medical history. Chi-square tests, t-tests, and logistic regression analysis identified stenosis risk factors.
Results:
Among 30 patients generating 1,462 AVF sound recordings, abnormal AVF sound was defined as <-28.59 dB using three-standard-deviation analysis. One patient developed clinically apparent stenosis during the study period. Retrospective analysis revealed electronic stethoscope detected stenosis one month before clinical diagnosis. Logistic regression identified significant risk factors for stenosis (percutaneous transluminal angioplasties (PTA) within 3 years): diabetes mellitus (OR=18.67, p=0.005), hypertension (p=0.019), body mass index ≤25 (p=0.006), higher mean systolic BP (OR=1.82 per 10mmHg, p=0.018), FX dialyzer type (OR=5.25, p=0.048), and greater number of prior PTAs (OR=2.47, p=0.003).
Conclusions:
Electronic stethoscope monitoring demonstrated potential for earlier AVF stenosis detection compared to traditional clinical assessment. The identified risk factors—including a novel association with FX dialyzer use—can guide targeted surveillance protocols. Implementing objective acoustic monitoring may improve timely intervention and AVF longevity in high-risk HD patients. Clinical Trial: The study protocol was approved by the Institutional Review Board of NTUH (IRB No. 202302099RINA) and registered at ClinicalTrials.gov (NCT07436559).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.